A novel inhibitor of Smad‐dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis
Minoru Hasegawa(University of Fukui), Shinichi Sato(University of Tokyo Hospital), Kiyoshi Higashi(Sumitomo Chemical (Japan)), Mayuka Horikawa(Kanazawa University), Hideo Kaneko(Chiba University), Fumiaki Shirasaki(Kanazawa University), Kazuhiko Takehara(Kanazawa University), Yoshitaka Tomigahara(Sumitomo Chemical (Japan)), Yukiyo Matsushita(Kanazawa University), Manabu Fujimoto(Osaka Gakuin University)
Cited by 51
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438